Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuanyuan Jiang, Lanxin Liu, Morenci Manning, Madison Bonahoom, Aaron Lotvola, Zhe Yang & Zeng-Quan Yang. (2022) Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus. Journal of Biomolecular Structure and Dynamics 40:3, pages 1331-1346.
Read now
Read now
Werner J Geldenhuys & Cornelis J Van der Schyf. (2013) Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders. Expert Opinion on Drug Discovery 8:2, pages 115-129.
Read now
Read now
Articles from other publishers (36)
Daniela Catarzi, Flavia Varano, Sara Calenda, Erica Vigiani & Vittoria Colotta. 2023.
Gaofenngwe Nkomba, Gisella Terre’Blanche, Helena D. Janse van Rensburg & Lesetja J. Legoabe. (2022) Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A1 receptors for the potential treatment of epilepsy. Medicinal Chemistry Research 31:8, pages 1277-1297.
Crossref
Crossref
Jon Kyle Awalt, Anh T.N. Nguyen, Tim J. Fyfe, Bui San Thai, Paul J. White, Arthur Christopoulos, Manuela Jörg, Lauren T. May & Peter J. Scammells. (2022)
Examining the Role of the Linker in Bitopic
N
6
-Substituted Adenosine Derivatives Acting as Biased Adenosine A
1
Receptor Agonists
. Journal of Medicinal Chemistry 65:13, pages 9076-9095.
Crossref
Crossref
Pallabi Banerjee & Imteyaz Qamar. 2022. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology
195
213
.
Nicholas J. Wright & Seok-Yong Lee. (2020) Toward a Molecular Basis of Cellular Nucleoside Transport in Humans. Chemical Reviews 121:9, pages 5336-5358.
Crossref
Crossref
Lingtong Meng, Cuirong Wang, Yaping Lu, Gang Sheng, Lin Yang, Zhouyue Wu, Hang Xu, Chao Han, Yingmei Lu & Feng Han. (2021) Targeted Regulation of Blood–Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma. ACS Applied Materials & Interfaces 13:10, pages 11657-11671.
Crossref
Crossref
D. Douglas Miller. 2021. Atlas of Nuclear Cardiology. Atlas of Nuclear Cardiology
125
160
.
Sneha Shaw, Ankit Uniyal, Anagha Gadepalli, Vineeta Tiwari, Daria A. Belinskaia, Natalia N. Shestakova, Katharigatta N. Venugopala, Pran Kishore Deb & Vinod Tiwari. (2020) Adenosine receptor signalling: Probing the potential pathways for the ministration of neuropathic pain. European Journal of Pharmacology 889, pages 173619.
Crossref
Crossref
Wiwin Is Effendi, Tatsuya Nagano, Kazuyuki Kobayashi & Yoshihiro Nishimura. (2020) Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. Cells 9:3, pages 785.
Crossref
Crossref
Omar H.A. Al-Attraqchi, Mahesh Attimarad, Katharigatta N. Venugopala, Anroop Nair & Noor H.A. Al-Attraqchi. (2019) Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives. Current Pharmaceutical Design 25:25, pages 2716-2740.
Crossref
Crossref
Pran Kishore Deb, Satyendra Deka, Pobitra Borah, Sara N. Abed & Karl-Norbert Klotz. (2019) Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives. Current Pharmaceutical Design 25:25, pages 2697-2715.
Crossref
Crossref
Trevor Simard, Richard Jung, Alisha Labinaz, Mohammad Ali Faraz, F. Daniel Ramirez, Pietro Di Santo, Ian Pitcher, Pouya Motazedian, Chantal Gaudet, Rebecca Rochman, Jeffrey Marbach, Paul Boland, Kiran Sarathy, Saleh Alghofaili, Juan J. Russo, Etienne Couture, Rob S. Beanlands & Benjamin Hibbert. (2019) Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective. Cardiovascular & Hematological Disorders-Drug Targets 19:2, pages 109-131.
Crossref
Crossref
Maan T. Khayat, Ahmad Hanif, Werner J. Geldenhuys & Mohammed A. Nayeem. 2019. Frontiers in Cardiovascular Drug Discovery: Volume 4. Frontiers in Cardiovascular Drug Discovery: Volume 4
65
82
.
Jae Woo KimJong Been LeeSo Hyung Lee. (2019) Effect and Mechanism of Phosphodiesterase Inhibitors on Trabecular Outflow. Korean Journal of Ophthalmology 33:5, pages 414.
Crossref
Crossref
Marta Mateus, Marcus M. Ilg, William J. Stebbeds, Nim Christopher, Asif Muneer, David J. Ralph & Selim Cellek. (2018) Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie’s Disease. The Journal of Sexual Medicine 15:7, pages 947-957.
Crossref
Crossref
Luigi Aurelio, Jo-Anne Baltos, Leigh Ford, Anh T. N. Nguyen, Manuela Jörg, Shane M. Devine, Celine Valant, Paul J. White, Arthur Christopoulos, Lauren T. May & Peter J. Scammells. (2018)
A Structure–Activity Relationship Study of Bitopic
N
6
-Substituted Adenosine Derivatives as Biased Adenosine A
1
Receptor Agonists
. Journal of Medicinal Chemistry 61:5, pages 2087-2103.
Crossref
Crossref
Riccardo Petrelli, Mirko Scortichini, Carmela Belardo, Serena Boccella, Livio Luongo, Fabio Capone, Sonja Kachler, Patrizia Vita, Fabio Del Bello, Sabatino Maione, Antonio Lavecchia, Karl-Norbert Klotz & Loredana Cappellacci. (2018)
Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A
1
Adenosine Receptor Agonists
. Journal of Medicinal Chemistry 61:1, pages 305-318.
Crossref
Crossref
Daniela Salvemini, Timothy M. Doyle, Tally M. Largent-Milnes & Todd W. Vanderah. 2018. The Adenosine Receptors. The Adenosine Receptors
413
437
.
Fernanda Francine Zimmermann, Karina Vidarte Gaspary, Anna Maria Siebel, Carlos Eduardo Leite, Luiza Wilges Kist, Mauricio Reis Bogo & Carla Denise Bonan. (2016) Analysis of Extracellular Nucleotide Metabolism in Adult Zebrafish After Embryological Exposure to Valproic Acid. Molecular Neurobiology 54:5, pages 3542-3553.
Crossref
Crossref
J. Daniel Hothersall, Dong Guo, Sunil Sarda, Robert J. Sheppard, Hongming Chen, Wesley Keur, Michael J. Waring, Adriaan P. IJzerman, Stephen J. Hill, Ian L. Dale & Philip B. Rawlins. (2017) Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics. Molecular Pharmacology 91:1, pages 25-38.
Crossref
Crossref
Michael Freissmuth & Karl-Norbert Klotz. 2017. Adenosine Receptors in Neurodegenerative Diseases. Adenosine Receptors in Neurodegenerative Diseases
3
22
.
Silvia Nov?o, Mar?a Jes?s N??ez-Iglesias & Manuel Freire-Garabal. 2017. Molecular Oncology: Underlying Mechanisms and Translational Advancements. Molecular Oncology: Underlying Mechanisms and Translational Advancements
93
107
.
Katia Varani, Fabrizio Vincenzi, Stefania Merighi, Stefania Gessi & Pier Andrea Borea. 2017. Protein Reviews. Protein Reviews
193
232
.
Manuela Jörg, Alisa Glukhova, Alaa Abdul-Ridha, Elizabeth A. Vecchio, Anh T. N. Nguyen, Patrick M. Sexton, Paul J. White, Lauren T. May, Arthur Christopoulos & Peter J. Scammells. (2016)
Novel Irreversible Agonists Acting at the A
1
Adenosine Receptor
. Journal of Medicinal Chemistry 59:24, pages 11182-11194.
Crossref
Crossref
K Janes, AM Symons-Liguori, K A Jacobson & D Salvemini. (2016)
Identification of A
3
adenosine receptor agonists as novel non-narcotic analgesics
. British Journal of Pharmacology 173:8, pages 1253-1267.
Crossref
Crossref
Amarendra Panda, Suresh Satpati, Anshuman Dixit & Shantanu Pal. (2016)
Novel homologated-apio adenosine derivatives as A
3
adenosine receptor agonists: design, synthesis and molecular docking studies
. RSC Advances 6:14, pages 11233-11239.
Crossref
Crossref
Samira Mousavi, Mojtaba Panjehpour, Mohammad Hossein Izadpanahi & Mahmoud Aghaei. (2015) Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues. The Prostate 75:7, pages 735-747.
Crossref
Crossref
Keizo Kohno, Emiko Ohashi, Osamu Sano, Hajime Kusano, Toshio Kunikata, Norie Arai, Toshiharu Hanaya, Toshio Kawata, Tomoyuki Nishimoto & Shigeharu Fukuda. (2015) Anti-inflammatory effects of adenosine N1-oxide. Journal of Inflammation 12:1, pages 2.
Crossref
Crossref
Franciszek Burdan. 2015. Coffee in Health and Disease Prevention. Coffee in Health and Disease Prevention
823
829
.
Anna Vittoria Mattioli. 2015. Coffee in Health and Disease Prevention. Coffee in Health and Disease Prevention
691
698
.
Anna Eisenstein, Shannon H. Carroll, Hillary Johnston-Cox, Melissa Farb, Noyan Gokce & Katya Ravid. (2014) An Adenosine Receptor-Krüppel-like Factor 4 Protein Axis Inhibits Adipogenesis. Journal of Biological Chemistry 289:30, pages 21071-21081.
Crossref
Crossref
Shane M. Devine, Lauren T. May & Peter J. Scammells. (2014)
Design, synthesis and evaluation of N
6
-substituted 2-aminoadenosine-5?-N-methylcarboxamides as A
3
adenosine receptor agonists
. Med. Chem. Commun. 5:2, pages 192-196.
Crossref
Crossref
Eli Iacob, Kathleen C Light, Scott C Tadler, Howard R Weeks, Andrea T White, Ronald W Hughen, Timothy A VanHaitsma, Lowry Bushnell & Alan R Light. (2013) Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls. BMC Psychiatry 13:1.
Crossref
Crossref
Susan A. Masino, Masahito KawamuraJr.Jr., Jessica L. Cote, Rebecca B. Williams & David N. Ruskin. (2013) Adenosine and autism: A spectrum of opportunities. Neuropharmacology 68, pages 116-121.
Crossref
Crossref
Rafael Perígolo-Vicente, Karen Ritt, Mariana Rodrigues Pereira, Patrícia Maria Mendonça Torres, Roberto Paes-de-Carvalho & Elizabeth Giestal-de-Araujo. (2013) IL-6 treatment increases the survival of retinal ganglion cells in vitro: The role of adenosine A1 receptor. Biochemical and Biophysical Research Communications 430:2, pages 512-518.
Crossref
Crossref
J.C. Lim & C.H. Mitchell. (2012) Inflammation, Pain, and Pressure—Purinergic Signaling in Oral Tissues. Journal of Dental Research 91:12, pages 1103-1109.
Crossref
Crossref